AI-based image processing startup In-Med Prognostics has raised $2.13 million in a fresh funding round led by Exxora, with participation from several angel investors .
The capital will be used for expanding the product portfolio and tapping global markets, the company said in a press statement.
Founded by Latha Poonamallee and Rajesh Purushottam, In-Med Prognostics offers AI-powered image processing proprietary software for neurologist decision support and radiologist workflow enhancement. It uses deep learning algorithms and machine learning to provide Neuro analysis, which further aids in assessment and early detection of neurological disorders such as Dementia, Alzheimer’s, and Parkinson’s.
The startup claims its ‘Neuroshield’ solution provides a self-explanatory volumetric report within an analysis time of 20 minutes.
In-Med India had announced a Rs 50 lakh Grant from BIRAC in 2019. In-Med Inc, the US holding company, was formed in 2021. Since then, it has also expanded its footprint to Africa.
In India, In-Med Prognostics works with Aarthi Scans, Scansworld, Gujarat Scans, Nanavati, and Cauvery hospitals.
